Biotech Convertible Notes: Redemption or Conversion?

Does a redemption announcement mean the full principal leaves cash?

For biotech convertible notes, a call announcement alone does not establish the final cash outflow. Reconcile the named note series through conversion elections, actual shares issued, principal paid in cash and the remaining balance. A future maturity date is insufficient once later disclosures describe a call or settlement.

This is a repeatable evidence task for a financing review: determine which funding obligation remains before evaluating a milestone or ownership scenario. It does not predict which choice holders will make. The historical example below was reviewed against SEC originals on October 16, 2026; it does not describe Insmed's current capital structure.

Put the call and the conversion deadline on different lines

Insmed's April 24, 2025 Form 8-K, Item 8.01 announced redemption of the remaining $569.5 million of its 0.75% convertible senior notes due 2028 on June 6, 2025. It also specified a June 4, 2025, 5 p.m. New York City conversion deadline, with an exception if the redemption price was not paid, and the company's election to settle conversions in common shares.

Those terms pose two different questions: what would be payable for notes still outstanding at redemption, and what would happen to notes converted beforehand? Do not label the announced principal as a completed cash payment. For another issuer, read that issuer's notice and governing terms rather than copying this deadline or settlement election.

Close the event with the later statement and debt note

Insmed's 2025 Form 10-K, Note 10 and consolidated cash-flow statement provides the later evidence:

Reported item	Amount and scope
Principal converted after April 24, 2025	$567.5 million, reported in rounded millions
Shares issued for those conversions	17,756,196 common shares
Conversion rate for that group	31.2861 shares per $1,000 principal
2025 cash-flow principal payments for the 0.75% notes due 2028	1,965 in USD thousands, or $1.965 million
Convertible-note face value at December 31, 2025	Zero in the note's balance table

The principal-payment line is not an all-in settlement cost: interest requires separate reconciliation. The zero convertible balance also does not establish zero debt across every instrument.

For a cash bridge, use the disclosed cash-payment category with its sign and period. For ownership, use the actual issuance disclosure with its event scope. Neither the redemption headline nor the disappearance of a debt balance replaces both pieces of evidence.

Check rounded amounts without inventing precision

The reported conversion figures illustrate a useful limit. Multiplying $567.5 million ÷ $1,000 × 31.2861 gives 17,754,861.75 shares. That calculation uses rounded disclosed inputs; it does not reconstruct the reported 17,756,196 shares exactly. Keep the filing's actual issuance count and flag the missing unrounded detail rather than silently changing the count or alleging an error.

Likewise, subtracting a later rounded conversion amount from an earlier rounded redemption announcement is not a substitute for the principal cash-payment line. Preserve the different dates and precisions. A discrepancy becomes a question for reconciliation, not an invitation to manufacture a balancing figure.

For a new transaction, this worksheet keeps the missing evidence visible:

Field to reconcile	Evidence needed before using it
Opening principal	Exact series, balance date and face-value basis
Conversion	Event dates, principal retired and actual shares issued
Cash redemption	Principal paid, payment period and separate interest evidence
Closing principal	Later balance for the same series, including other changes

Do not substitute carrying value net of issuance costs for face principal without an explicit bridge. If the amounts or periods cannot be aligned, leave the residual UNKNOWN.

Turn the reconciliation into a company-specific question

The cash-runway worksheet addresses usable funding; the ATM guide distinguishes equity capacity from completed sales; the EPS guide separates an accounting denominator from future ownership. This note-series review answers a different question: which debt was retired through shares and which through cash?

Choose a company in the existing valuation-assumptions task and review the prepared question. Add the exact note series, dated filings and this request: reconcile principal converted, shares actually issued, principal cash payments and the closing note balance, leaving unsupported amounts unknown. Review the required credits before manually running a question. The dated example is a worksheet, not current company evidence automatically supplied to the task.